Advertisement
Original article| Volume 32, ISSUE 3, P180-190, March 2010

Download started.

Ok

X-linked adrenoleukodystrophy: Clinical course and minimal incidence in South Brazil

      Abstract

      X-linked adenoleukodystrophy is a genetic disease that affects the degradation of very long-chain fatty acids. In male patients, common pictures are the cerebral form (CALD), myeloneuropathy (AMN), and Addison-only. Objective: To describe the clinical course of affected male patients from South Brazil between 1993 and 2007. Methods: Affected male patients and their maternal lineages were studied from a clinical, neurological and biochemical standpoint. Results: Eighty-three male patients from 30 families were biochemically evaluated: 51 were affected. 27/51 (54%) presented the cerebral form; 11/51 had AMN (22%); 5 had Addison-only (10%), and 8 (16%) were asymptomatic. Between 2002 and 2006, the minimal incidence was 1:35,000 males in our State (South Brazil). Forty-three affected individuals were followed for 5.4 ± 3.7 years. Of 10 boys detected at early stages, three developed CALD. These three boys and another five CALD at baseline were referred to hematopoietic stem cell transplantation. Seven transplants were carried out, 5 with good clinical evolution after 2.2 years post-transplant. The non-transplanted case was later defined as a stable cerebral form. Discussion: Among the present families, the observed cases were comparable to the 50% expected by Mendelian segregation. Based on the natural history, the number of cases that developed CALD was similar to the expected. Transplants were successful in 70% of cases. The occurrence of a stable cerebral form pointed to an urgent need for better markers of active cerebral disease.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bezman L.
        • Moser A.B.
        • Raymond G.V.
        • Rinaldo P.
        • Watkins P.A.
        • Smith K.D.
        • et al.
        Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening.
        Ann Neurol. 2001; 49: 512-517
        • Moser H.W.
        • Smith K.D.
        • Watkins P.A.
        • Powers J.
        • Moser A.B.
        X-linked adrenoleukodystrophy.
        in: Scriver C.R. Beaudet A.L. Sly W.S. Valle D. The metabolic and molecular bases of inherited disease. McGraw Hill, New York2001: 3257-3301
        • Peters C.
        • Charnas L.R.
        • Tan Y.
        • Ziegler R.S.
        • Shapiro E.G.
        • DeFor T.
        • et al.
        Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.
        Blood. 2004; 104: 881-888
        • Beam D.
        • Poe M.D.
        • Provenzale J.M.
        • Szabolcs P.
        • Martin P.L.
        • Prasad V.
        • et al.
        Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
        Biol Blood Marrow Transplant. 2007; 13: 665-674
        • Loes D.J.
        • Hite S.
        • Moser H.
        • Stillman A.E.
        • Shapiro E.
        • Lockman L.
        • et al.
        Adrenoleukodystrophy: a scoring method for brain MR observations.
        Am J Neuroradiol. 1994; 15: 1761-1766
        • Rizzo W.B.
        • Leshner R.T.
        • Odone A.
        • Dammann A.L.
        • Craft D.A.
        • Jensen M.E.
        • et al.
        Dietary erucic acid therapy for X-linked adrenoleukodystrophy.
        Neurology. 1989; 39: 1415-1422
        • van Geel B.M.
        • Assies J.
        • Haverkort E.B.
        • Koelman J.H.
        • Verbeeten Jr., B.
        • Wanders R.J.
        • et al.
        Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with “Lorenzo’s oil”.
        J Neurol Neurosurg Psychiatry. 1999; 67: 290-299
        • Moser H.W.
        • Raymond G.V.
        • Lu S.E.
        • Muenz L.R.
        • Moser A.B.
        • Xu J.
        • et al.
        Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo’s oil.
        Arch Neurol. 2005; 62: 1073-1080
        • Moser H.W.
        Therapy of X-linked adrenoleukodystrophy.
        NeuroRx. 2006; 3: 246-253
        • Kemp S.
        • Wanders R.J.
        X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.
        Mol Genet Metab. 2007; 90: 268-276
        • Vargas C.R.
        • Barschak A.G.
        • Coelho D.M.
        • Souza C.F.M.
        • Karam S.M.
        • Jardim L.B.
        • et al.
        Clinical and biochemical findings in 7 patients with X-linked adrenoleukodystrophy treated with Lorenzo’s Oil.
        Genet Mol Biol. 2000; 23: 697-701
        • Moser A.B.
        • Kreiter N.
        • Bezman L.
        • Lu S.
        • Raymond G.V.
        • Naidu S.
        • et al.
        Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls.
        Ann Neurol. 1999; 45: 100-110
        • Lange M.C.
        • Teive H.A.
        • Troiano A.R.
        • Bitencourt M.
        • Funke V.A.
        • Setúbal D.C.
        • et al.
        Bone marrow transplantation in patients with storage diseases: a developing country experience.
        Arq Neuropsiquiatr. 2006; 64: 1-4
        • Kirk E.P.E.
        • Fletcher J.M.
        • Sharp P.
        • Carey B.
        • Poulos A.
        X-linked adrenoleukodystrophy: the Australasian experience.
        Am J Med Genet. 1998; 76: 420-423
        • Ruiz M.
        • Coll M.J.
        • Pampols T.
        • Giros M.
        X-linked adrenoleukodystrophy: phenotype distribution and expression of ALDP in Spanish kindreds.
        Am J Med Genet. 1998; 76: 424-427
        • Shapiro E.
        • Krivit W.
        • Lockman L.
        • Jambaqué I.
        • Peters C.
        • Cowan M.
        • et al.
        Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy.
        Lancet. 2000; 356: 713-718
        • Moser H.W.
        • Fatemi A.
        • Zackowski K.
        • Smith S.
        • Golay X.
        • Muenz L.
        • et al.
        Evaluation of therapy of X-linked adrenoleukodystrophy.
        Neurochem Res. 2004; 29: 1003-1016